This inventor holds 1 USPTO granted patent. Top assignee: Synthego Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Morteza Miansarigavzan: Innovator in Automated Oligonucleotide Synthesis
Introduction
Morteza Miansarigavzan is a notable inventor based in Redwood City, California. He has made significant contributions to the field of biotechnology, particularly in the area of automated oligonucleotide synthesis. His innovative work has the potential to advance various applications in genetic research and therapeutic development.
Latest Patents
Morteza holds a patent for a system and method for automated oligonucleotide synthesis. The patent describes a reactor system that includes a vessel designed to contain a solid support. This vessel features a wall that defines a reaction chamber, which has a first end and a second end. A piston is operatively arranged at the first end and is configured to translate within the reaction chamber. Additionally, a force measuring device is coupled to the piston to measure the load on it. The system also includes a piston driver and a processor that is operably connected to both the force measuring device and the piston driver. The processor is designed to measure the load on the piston and adjust its position accordingly.
Career Highlights
Morteza is currently employed at Synthego Corporation, where he continues to work on innovative solutions in the field of biotechnology. His expertise and dedication to research have positioned him as a valuable asset to his team and the industry.
Collaborations
Morteza collaborates with various professionals in his field, including his coworker, Sammy Datwani. Their combined efforts contribute to the advancement of technologies that enhance oligonucleotide synthesis.
Conclusion
Morteza Miansarigavzan is a pioneering inventor whose work in automated oligonucleotide synthesis is shaping the future of biotechnology. His contributions are essential for the ongoing development of genetic research and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
